COVID-19 booster for immunosuppressed patients with inflammatory bowel disease

By | October 14, 2021
Researchers have published correspondence detailing the reasoning behind providing a third booster dose to patients with inflammatory bowel disease that have been treated with drugs that can reduce the response to the COVID-19 vaccines.